Pharmaceutical Technology, JanuaryFebruary 2025

February 10, 2025

Application of AI/ML technology and a burst of M&A activity look to be shaping the future of the pharma industry.

February 09, 2025

Survey results show that being intellectually stimulated and getting assigned challenging projects are two key drivers of employee satisfaction, yet job training is lacking.

February 08, 2025

European biopharma companies are looking beyond GLP-1s.

February 07, 2025

Increasing API and formulation complexity and new delivery strategies are driving innovations in taste-masking.

February 06, 2025

Rapid market growth in biologics is helping the packaging market expand as well, but the complex nature of biologics and the desire for personalized therapies present unique hurdles to make packaging solutions cost-effective and safe for patients.

February 06, 2025

Process consistency and robustness, analytical excellence, and regulatory compliance are essential in the scale-up of biosimilars.

February 05, 2025

Developers save money and time while accessing expertise.

February 04, 2025

The optimization of processes for the development and manufacture of biopharmaceuticals is pivotal for producing quality products.

February 04, 2025

CDMOs who have integrated technologies can help further the advancement of ADC development.

February 03, 2025

EMA introduced its New Fee Regulation in January 2025, but what impact will the new fees and charges have on medicine developers?

February 02, 2025

Bio/pharma companies have a lot to consider when tackling social media communications, especially within Europe.

January 31, 2025

If the conditions prove optimal, 2025 could be a prosperous year for bio/pharma business deals.

January 31, 2025

AI regulations in healthcare are rapidly evolving, and one should consult with regulatory subject matter experts, says Siegfried Schmitt, PhD, vice president, Technical at Parexel.